Optimizing the clarification process in cell culture and fermentation broth is often underestimated in its impact on critical quality attributes (CQA) in biotech processes. Merck researchers challenge this notion, highlighting the significance of clarification in the context of rising cell densities, advancements in up- and downstream processing, and the adoption of quality by design (QbD) principles.
The application of QbD principles to the optimization of clarification processes can lead to better control over process impurities and the establishment of a robust quality control strategy that integrates quality throughout the process, as emphasized by scientists at Merck in a recent paper.
QbD has evolved beyond a risk management concept to a practice focused on designing and developing manufacturing processes during product development to consistently ensure predefined quality outcomes. This shift underscores the importance of proactive quality management throughout the entire manufacturing process.
In a study led by Kyeong-won (Kevin) Yeop and a team at Merck, a harvest clarification process for an extracellular product was meticulously designed. By utilizing a leachables risk assessment model, the team demonstrated how altering the clarification process can impact the risk profile, emphasizing the need for strategic decision-making in process design.
The team at Merck further elucidated the interplay between critical process parameters and CQAs, highlighting the role of various substances in influencing solute concentrations critical for maintaining osmotic pressure in cells. Changes in osmolarity during clarification can have cascading effects on cell integrity and filtrate quality, underscoring the need for precision in process control.
Factors such as flux, conductivity, and pH buffer conditions were identified as key determinants of CQAs, suggesting that subtle variations in these parameters can significantly impact product quality. By applying QbD principles to the clarification process, manufacturers can align process parameters with quality targets, thereby enhancing overall product quality and regulatory compliance.
Through rigorous risk assessments and the application of design of experiments methodologies, the Merck team systematically optimized critical process parameters to enhance product safety, quality, and manufacturing reliability. This approach not only streamlines the relationship between process parameters and product quality but also ensures a systematic approach to process optimization.
The implementation of QbD standards in the clarification process not only elevates product quality and safety but also fortifies manufacturing processes, ensuring consistency and compliance throughout the product lifecycle. By embracing this methodology, biomanufacturers can drive continuous improvement, optimize processes, and uphold stringent regulatory standards.
Key Takeaways:
– The optimization of the clarification process plays a pivotal role in enhancing critical quality attributes (CQA) in biotech processes.
– Applying quality by design (QbD) principles to clarification processes enables better control over impurities and fosters a robust quality control strategy.
– Understanding the intricate relationship between critical process parameters and CQAs is essential for optimizing product quality and ensuring regulatory compliance.
– Rigorous risk assessments and design of experiments methodologies help streamline process optimization and enhance manufacturing reliability.
Tags: quality control, regulatory, downstream, biotech, cell culture, upstream, process development
Read more on genengnews.com